What are the major opportunities in the Antipsychotic Drugs market? What are the strategies for the Antipsychotic Drugs market?

For detailed insights on the major opportunities and strategies in the Antipsychotic Drugs market, Read More

How does the Antipsychotic Drugs market relate to the overall economy and other similar markets?

For detailed insights on Antipsychotic Drugs's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Antipsychotic Drugs market growth? SWOT analysis of the Antipsychotic Drugs market.

For detailed insights on the key dynamics influencing the Antipsychotic Drugs market growth and SWOT analysis of the Antipsychotic Drugs industry, Read More

Antipsychotic Drugs Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Antipsychotic Drugs Market Report 2026

Name: Antipsychotic Drugs Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Therapeutic Class (First Generation, Second Generation, Third Generation), By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases), By Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Antipsychotic Drugs Market Overview

• Antipsychotic Drugs market size has reached to $21.25 billion in 2025

• Expected to grow to $33.26 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%

• Growth Driver: Rising Mental Disorders Fuel Growth Of Antipsychotic Drugs Market

• Market Trend: Advancements In Subcutaneous Antipsychotic Injections For Enhanced Patient Compliance And Efficacy

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Antipsychotic Drugs Market?

Antipsychotic drugs are a class of medications used primarily to manage and treat symptoms of psychosis, which can include delusions, hallucinations, paranoia, and disordered thinking. Psychosis is commonly associated with psychiatric conditions such as schizophrenia, bipolar disorder, and severe depression. These medications are also sometimes referred to as neuroleptics or major tranquilizers.

The main therapeutic class types of antipsychotic drugs are first-generation, second-generation, and third-generation. First-generation drugs were the earliest developed and work mainly by blocking dopamine receptors in the brain, which can help reduce hallucinations and delusions. They are used in various diseases such as schizophrenia, bipolar disorder, unipolar depression, dementia, and others and are sold through several distribution channels, including hospital pharmacies, drug stores, and online pharmacies.

Antipsychotic Drugs Market Global Report 2026 Market Report bar graph

What Is The Antipsychotic Drugs Market Size and Share 2026?

The antipsychotic drugs market size has grown strongly in recent years. It will grow from $21.25 billion in 2025 to $23.23 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to introduction of first-generation antipsychotics, growing awareness of mental health disorders, expansion of hospital and clinical infrastructure, rising prevalence of schizophrenia and bipolar disorder, increased r&d investments in neuropsychiatric drugs.

What Is The Antipsychotic Drugs Market Growth Forecast?

The antipsychotic drugs market size is expected to see strong growth in the next few years. It will grow to $33.26 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to advancements in atypical and partial dopamine agonists, adoption of precision medicine approaches, integration of ai in mental health diagnostics, expansion of online pharmacy distribution, increasing focus on long-acting injectable formulations. Major trends in the forecast period include personalized antipsychotic therapy, rising geriatric population, increasing prevalence of schizophrenia and bipolar disorder, telepsychiatry and digital mental health platforms, development of long-acting injectable antipsychotics.

Book your 30 minutes free consultation with our research experts

Global Antipsychotic Drugs Market Segmentation

1) By Therapeutic Class: First Generation, Second Generation, Third Generation

2) By Disease: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases

3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By First Generation: Typical Antipsychotics, Phenothiazines, Butyrophenones, Thioxanthenes, Dibenzoxazepines

2) By Second Generation: Atypical Antipsychotics, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripiprazole, Paliperidone, Lurasidone

3) By Third Generation: Partial Dopamine Agonists, Aripiprazole, Brexpiprazole, Cariprazine

What Is The Driver Of The Antipsychotic Drugs Market?

The growing incidence of mental disorders is expected to propel the growth of the antipsychotic drug market going forward. Mental disorders, often known as mental illnesses, are ailments that impact a person's thinking, behavior, mood, and mental health. The mental disorder cases can be affected by stress levels, societal pressures, genetic predisposition, biochemical imbalance, neurodevelopmental issues, and physical health conditions. Antipsychotic drugs control mental disorders by altering the activity of neurotransmitters, primarily dopamine and serotonin, to reduce psychotic symptoms, stabilize mood, and improve cognitive and emotional function. For instance, in November 2023, according to a survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), a US-based government agency for public health, approximately 6% of adults aged 18 or older, equivalent to 15.4 million individuals, reported experiencing serious mental illness (SMI). Furthermore, in September 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the number of individuals living with dementia in Australia is expected to more than double from around 411,100 in 2023 to 849,300 by 2058. This increase will affect approximately 315,500 men and 533,800 women. Therefore, a growing incidence of mental disorders is driving the antipsychotic drug industry.

Key Players In The Global Antipsychotic Drugs Market

Major companies operating in the antipsychotic drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., H. Lundbeck A/S, Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Alkermes plc

Global Antipsychotic Drugs Market Trends and Insights

Major companies operating in the antipsychotic drug market are focused on developing advanced medical products, such as subcutaneous atypical antipsychotic injections, to offer improved patient compliance and enhanced efficacy compared to traditional oral medications. Subcutaneous atypical antipsychotic injections are psychiatric drugs that are given under the skin to treat mental illnesses, maintain stable blood levels, and improve symptom control. For instance, in April 2023, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, and MedinCell SA, a France-based manufacturer of biological products and pharmaceutical preparations, launched U.S. Food and Drug Administration (FDA)-approved UZEDY. It is an extended-release injectable formulation of risperidone designed as a long-acting subcutaneous injection that offers flexible dosing intervals of one or two months. UZEDY utilizes MedinCell's proprietary SteadyTeq technology, which ensures a steady release of the medication, reaching therapeutic levels within 6–24 hours of administration. In clinical trials, UZEDY demonstrated up to an 80% reduction in the risk of schizophrenia relapse compared to placebo. It is intended to address adherence issues commonly associated with oral antipsychotics, which often lead to relapse.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Antipsychotic Drugs Market?

In March 2024, Bristol-Myers Squibb, a US-based pharmaceutical company, acquired Karuna Therapeutics Inc. for $14 billion. The acquisition aims to significantly enhance Bristol Myers Squibb's neuroscience portfolio by integrating Karuna's innovative antipsychotic treatment, KarXT. Additionally, the deal provides access to Karuna's early-stage and preclinical pipeline, which may further contribute to the company's long-term growth and diversification in neuroscience. Karuna Therapeutics Inc. is a US-based clinical-stage biopharmaceutical company that develops the treatment of psychiatric and neurological conditions.

Regional Insights

North America was the largest region in the antipsychotic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Antipsychotic Drugs Market?

The antipsychotic drugs market consists of sales of long-acting injectables, depot injections, and atypical antipsychotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Antipsychotic Drugs Market Report 2026?

The antipsychotic drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the antipsychotic drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Antipsychotic Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$23.23 billion
Revenue Forecast In 2035	$33.26 billion
Growth Rate	CAGR of 9.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Therapeutic Class, Disease, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Sun Phar
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Antipsychotic Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Antipsychotic Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Antipsychotic Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Antipsychotic Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Personalized Antipsychotic Therapy

4.2.2 Rising Geriatric Population

4.2.3 Increasing Prevalence Of Schizophrenia And Bipolar Disorder

4.2.4 Telepsychiatry And Digital Mental Health Platforms

4.2.5 Development Of Long-Acting Injectable Antipsychotics

5. Antipsychotic Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Psychiatric Clinics

5.3 Outpatient Care Centers

5.4 Online Pharmacies

5.5 Drug Stores

6. Antipsychotic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Antipsychotic Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Antipsychotic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Antipsychotic Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Antipsychotic Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Antipsychotic Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Antipsychotic Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Antipsychotic Drugs Market Segmentation

9.1. Global Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

First Generation, Second Generation, Third Generation

9.2. Global Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases

9.3. Global Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Drug Stores, Online Pharmacies

9.4. Global Antipsychotic Drugs Market, Sub-Segmentation Of First Generation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Typical Antipsychotics, Phenothiazines, Butyrophenones, Thioxanthenes, Dibenzoxazepines

9.5. Global Antipsychotic Drugs Market, Sub-Segmentation Of Second Generation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Atypical Antipsychotics, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripiprazole, Paliperidone, Lurasidone

9.6. Global Antipsychotic Drugs Market, Sub-Segmentation Of Third Generation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Partial Dopamine Agonists, Aripiprazole, Brexpiprazole, Cariprazine

10. Antipsychotic Drugs Market Regional And Country Analysis

10.1. Global Antipsychotic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Antipsychotic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Antipsychotic Drugs Market

11.1. Asia-Pacific Antipsychotic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Antipsychotic Drugs Market

12.1. China Antipsychotic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Antipsychotic Drugs Market

13.1. India Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Antipsychotic Drugs Market

14.1. Japan Antipsychotic Drugs Market Overview

14.2. Japan Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Antipsychotic Drugs Market

15.1. Australia Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Antipsychotic Drugs Market

16.1. Indonesia Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Antipsychotic Drugs Market

17.1. South Korea Antipsychotic Drugs Market Overview

17.2. South Korea Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Antipsychotic Drugs Market

18.1. Taiwan Antipsychotic Drugs Market Overview

18.2. Taiwan Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Antipsychotic Drugs Market

19.1. South East Asia Antipsychotic Drugs Market Overview

19.2. South East Asia Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Antipsychotic Drugs Market

20.1. Western Europe Antipsychotic Drugs Market Overview

20.2. Western Europe Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Antipsychotic Drugs Market

21.1. UK Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Antipsychotic Drugs Market

22.1. Germany Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Antipsychotic Drugs Market

23.1. France Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Antipsychotic Drugs Market

24.1. Italy Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Antipsychotic Drugs Market

25.1. Spain Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Antipsychotic Drugs Market

26.1. Eastern Europe Antipsychotic Drugs Market Overview

26.2. Eastern Europe Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Antipsychotic Drugs Market

27.1. Russia Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Antipsychotic Drugs Market

28.1. North America Antipsychotic Drugs Market Overview

28.2. North America Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Antipsychotic Drugs Market

29.1. USA Antipsychotic Drugs Market Overview

29.2. USA Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Antipsychotic Drugs Market

30.1. Canada Antipsychotic Drugs Market Overview

30.2. Canada Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Antipsychotic Drugs Market

31.1. South America Antipsychotic Drugs Market Overview

31.2. South America Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Antipsychotic Drugs Market

32.1. Brazil Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Antipsychotic Drugs Market

33.1. Middle East Antipsychotic Drugs Market Overview

33.2. Middle East Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Antipsychotic Drugs Market

34.1. Africa Antipsychotic Drugs Market Overview

34.2. Africa Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Antipsychotic Drugs Market Regulatory and Investment Landscape

36. Antipsychotic Drugs Market Competitive Landscape And Company Profiles

36.1. Antipsychotic Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Antipsychotic Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Antipsychotic Drugs Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

37. Antipsychotic Drugs Market Other Major And Innovative Companies

AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., H. Lundbeck A/S, Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Ltd.

38. Global Antipsychotic Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Antipsychotic Drugs Market

40. Antipsychotic Drugs Market High Potential Countries, Segments and Strategies

40.1 Antipsychotic Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Antipsychotic Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Antipsychotic Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Antipsychotic Drugs Market, Overview Of Key Products - Product Examples

Table 2: Global Antipsychotic Drugs Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Antipsychotic Drugs Market, Supply Chain Analysis

Table 4: Global Antipsychotic Drugs Market, Major Raw Material Providers

Table 5: Global Antipsychotic Drugs Market, Major Resource Providers

Table 6: Global Antipsychotic Drugs Market, Major Manufacturers (Suppliers)

Table 7: Global Antipsychotic Drugs Market, Major Distributors And Channel Partners

Table 8: Global Antipsychotic Drugs Market, Key Technologies & Future Trends

Table 9: Global Antipsychotic Drugs Market, Major Trends

Table 10: Global Antipsychotic Drugs Market, Major End Users

Table 11: Global Antipsychotic Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Antipsychotic Drugs Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Antipsychotic Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Antipsychotic Drugs Market - TAM, US$ Billion, 2025

Table 15: Global Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Antipsychotic Drugs Market, Sub-Segmentation Of First Generation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Antipsychotic Drugs Market, Sub-Segmentation Of Second Generation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Antipsychotic Drugs Market, Sub-Segmentation Of Third Generation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Antipsychotic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Antipsychotic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Antipsychotic Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Antipsychotic Drugs Market - Company Scoring Matrix

Table 97: Pfizer Inc. Financial Performance

Table 98: Johnson & Johnson Services Inc. Financial Performance

Table 99: Merck And Co. Inc. Financial Performance

Table 100: AbbVie Inc. Financial Performance

Table 101: Bristol-Myers Squibb Company Financial Performance

Table 102: Global Antipsychotic Drugs Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Antipsychotic Drugs Market, Competitive Dashboard

Table 104: Global Antipsychotic Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Antipsychotic Drugs Market Size Gain ($ Billion), Segmentation By Therapeutic Class, 2025 – 2030

Table 106: Global, Antipsychotic Drugs Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Table 107: Global, Antipsychotic Drugs Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Antipsychotic Drugs Market, Overview Of Key Products - Product Examples

Figure 2: Global Antipsychotic Drugs Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Antipsychotic Drugs Market, Supply Chain Analysis

Figure 4: Global Antipsychotic Drugs Market, Major Raw Material Providers

Figure 5: Global Antipsychotic Drugs Market, Major Resource Providers

Figure 6: Global Antipsychotic Drugs Market, Major Manufacturers (Suppliers)

Figure 7: Global Antipsychotic Drugs Market, Major Distributors And Channel Partners

Figure 8: Global Antipsychotic Drugs Market, Key Technologies & Future Trends

Figure 9: Global Antipsychotic Drugs Market, Major Trends

Figure 10: Global Antipsychotic Drugs Market, Major End Users

Figure 11: Global Antipsychotic Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Antipsychotic Drugs Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Antipsychotic Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Antipsychotic Drugs Market - TAM, US$ Billion, 2025

Figure 15: Global Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Antipsychotic Drugs Market, Sub-Segmentation Of First Generation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Antipsychotic Drugs Market, Sub-Segmentation Of Second Generation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Antipsychotic Drugs Market, Sub-Segmentation Of Third Generation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Antipsychotic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Antipsychotic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Antipsychotic Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Antipsychotic Drugs Market - Company Scoring Matrix

Figure 97: Pfizer Inc. Financial Performance

Figure 98: Johnson & Johnson Services Inc. Financial Performance

Figure 99: Merck And Co. Inc. Financial Performance

Figure 100: AbbVie Inc. Financial Performance

Figure 101: Bristol-Myers Squibb Company Financial Performance

Figure 102: Global Antipsychotic Drugs Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Antipsychotic Drugs Market, Competitive Dashboard

Figure 104: Global Antipsychotic Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Antipsychotic Drugs Market Size Gain ($ Billion), Segmentation By Therapeutic Class, 2025 – 2030

Figure 106: Global, Antipsychotic Drugs Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Figure 107: Global, Antipsychotic Drugs Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Dual Contaminant Pipe Market Report 2026 - Global Outlook – By Material Type (Polyvinyl Chloride, Chlorinated Polyvinyl Chloride, High-Density Polyethylene, Polyvinylidene Fluoride, Other Materials), By Technology (Conve...

Vendor Risk Management Market Report 2026 - Global Outlook – By Component (Solution, Services), By Deployment Mode (Cloud, On-Premises), By Organization Size (Small And Medium-Sized Enterprises, Large Enterprises), By Ve...

Dual Contaminant Pipe Market Report 2026 - Global Outlook – By Material Type (Polyvinyl Chloride, Chlorinated Polyvinyl Chloride, High-Density Polyethylene, Polyvinylidene Fluoride, Other Materials), By Technology (Conve...

Terminal Tractor Market Report 2026 - Global Outlook – By Type (Manual, Automated), By Propulsion (Diesel, Compressed Natural Gas (CNG), Hybrid, Electric), By Tonnage (Less Than 50 Ton, 50-100 Ton, Greater Than 100 Ton),...

Antidepressants Market Report 2026 - Global Outlook – By Product (Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhib...

Wire Harness Market Report 2026 - Global Outlook – By Product Type (Electric Wires, Connectors, Terminals, Other Products), By Material (PVC, Vinyl, Thermoplastic Elastomer, Polyurethane, Polyethylene ), By Application (...

Frequently Asked Questions

How big is the Antipsychotic Drugs Market?

The Antipsychotic Drugs market was valued at $21.25 billion in 2025, increased to $23.23 billion in 2026, and is projected to reach $33.26 billion by 2030.

What is the Antipsychotic Drugs market growth?

The global Antipsychotic Drugs market is expected to grow at a CAGR of 9.4% from 2026 to 2035 to reach $33.26 billion by 2035.

Who are the key players in Antipsychotic Drugs market?

Some Key Players in the Antipsychotic Drugs market Include, Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli L

Major trend in this market includes: Advancements In Subcutaneous Antipsychotic Injections For Enhanced Patient Compliance And Efficacy. For further insights on this market. request a sample here

North America was the largest region in the antipsychotic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipsychotic drugs market report are Asia-Pacific,

Book your 30 minutes free consultation with our research experts

Contact Us